Journey Medical Corporation (NASDAQ:DERM) Q4 2025 Earnings Call Transcript March 25, 2026
Journey Medical Corporation beats earnings expectations. Reported EPS is $-0.04, expectations were $-0.06.
Operator: Ladies and gentlemen, thank you for standing by. Good afternoon, and welcome to Journey Medical’s Full Year 2025 Financial Results and Corporate Update Conference Call. [Operator Instructions] Participants of this call are advised that the audio of this conference call is being broadcast...
